These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25472714)

  • 1. SEPT9 negatively regulates ubiquitin-dependent downregulation of EGFR.
    Diesenberg K; Beerbaum M; Fink U; Schmieder P; Krauss M
    J Cell Sci; 2015 Jan; 128(2):397-407. PubMed ID: 25472714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.
    Haglund K; Schmidt MHH; Wong ES; Guy GR; Dikic I
    EMBO Rep; 2005 Jul; 6(7):635-41. PubMed ID: 15962011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The basic amino acids in the coiled-coil domain of CIN85 regulate its interaction with c-Cbl and phosphatidic acid during epidermal growth factor receptor (EGFR) endocytosis.
    Zheng X; Zhang J; Liao K
    BMC Biochem; 2014 Jul; 15():13. PubMed ID: 25005938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex.
    Feng L; Wang JT; Jin H; Qian K; Geng JG
    Cell Biochem Funct; 2011 Oct; 29(7):589-96. PubMed ID: 21830225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking.
    Yoon HY; Kales SC; Luo R; Lipkowitz S; Randazzo PA
    Biol Cell; 2011 Apr; 103(4):171-84. PubMed ID: 21275903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIN85 phosphorylation is essential for EGFR ubiquitination and sorting into multivesicular bodies.
    Schroeder B; Srivatsan S; Shaw A; Billadeau D; McNiven MA
    Mol Biol Cell; 2012 Sep; 23(18):3602-11. PubMed ID: 22833562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Dyn2-CIN85 complex mediates degradative traffic of the EGFR by regulation of late endosomal budding.
    Schroeder B; Weller SG; Chen J; Billadeau D; McNiven MA
    EMBO J; 2010 Sep; 29(18):3039-53. PubMed ID: 20711168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex.
    Schmidt MHH; Hoeller D; Yu J; Furnari FB; Cavenee WK; Dikic I; Bögler O
    Mol Cell Biol; 2004 Oct; 24(20):8981-93. PubMed ID: 15456872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between the three CIN85 SH3 domains and ubiquitin: implications for CIN85 ubiquitination.
    Bezsonova I; Bruce MC; Wiesner S; Lin H; Rotin D; Forman-Kay JD
    Biochemistry; 2008 Aug; 47(34):8937-49. PubMed ID: 18680311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CIN85 regulates ubiquitination and degradative endosomal sorting of the EGF receptor.
    Rønning SB; Pedersen NM; Madshus IH; Stang E
    Exp Cell Res; 2011 Aug; 317(13):1804-16. PubMed ID: 21635887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors.
    Haglund K; Shimokawa N; Szymkiewicz I; Dikic I
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12191-6. PubMed ID: 12218189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinexin beta regulates the phosphorylation of epidermal growth factor receptor on the cell surface.
    Mitsushima M; Ueda K; Kioka N
    Genes Cells; 2006 Sep; 11(9):971-82. PubMed ID: 16923119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-independent degradation of epidermal growth factor receptor involves receptor ubiquitylation and Hgs, an adaptor whose ubiquitin-interacting motif targets ubiquitylation by Nedd4.
    Katz M; Shtiegman K; Tal-Or P; Yakir L; Mosesson Y; Harari D; Machluf Y; Asao H; Jovin T; Sugamura K; Yarden Y
    Traffic; 2002 Oct; 3(10):740-51. PubMed ID: 12230472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway.
    Peruzzi G; Molfetta R; Gasparrini F; Vian L; Morrone S; Piccoli M; Frati L; Santoni A; Paolini R
    J Immunol; 2007 Aug; 179(4):2089-96. PubMed ID: 17675467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis.
    Ahmed SF; Buetow L; Gabrielsen M; Lilla S; Sibbet GJ; Sumpton D; Zanivan S; Hedley A; Clark W; Huang DT
    Oncogene; 2021 Mar; 40(12):2149-2164. PubMed ID: 33627783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces.
    Liang Y; Kurakin A; Roizman B
    Proc Natl Acad Sci U S A; 2005 Apr; 102(16):5838-43. PubMed ID: 15824310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Septin 9 interacts with kinesin KIF17 and interferes with the mechanism of NMDA receptor cargo binding and transport.
    Bai X; Karasmanis EP; Spiliotis ET
    Mol Biol Cell; 2016 Mar; 27(6):897-906. PubMed ID: 26823018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.
    Ahmad G; Mohapatra BC; Schulte NA; Nadeau SA; Luan H; Zutshi N; Tom E; Ortega-Cava C; Tu C; Sanada M; Ogawa S; Toews ML; Band V; Band H
    Int J Biochem Cell Biol; 2014 Dec; 57():123-34. PubMed ID: 25449262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct roles of septins in cytokinesis: SEPT9 mediates midbody abscission.
    Estey MP; Di Ciano-Oliveira C; Froese CD; Bejide MT; Trimble WS
    J Cell Biol; 2010 Nov; 191(4):741-9. PubMed ID: 21059847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cbl promotes clustering of endocytic adaptor proteins.
    Jozic D; Cárdenes N; Deribe YL; Moncalián G; Hoeller D; Groemping Y; Dikic I; Rittinger K; Bravo J
    Nat Struct Mol Biol; 2005 Nov; 12(11):972-9. PubMed ID: 16228008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.